|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,250,000,000 |
Market
Cap: |
93.44(B) |
Last
Volume: |
20,542,542 |
Avg
Vol: |
12,077,193 |
52
Week Range: |
$40.25 - $64.73 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 97 |
Guru Rank Value : 8.6 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
13,571 |
13,571 |
Total Buy Value |
$0 |
$0 |
$672,994 |
$672,994 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
3 |
3 |
Total Shares Sold |
0 |
0 |
18,718 |
616,397 |
Total Sell Value |
$0 |
$0 |
$1,146,397 |
$44,859,834 |
Total People Sold |
0 |
0 |
2 |
5 |
Total Sell Transactions |
0 |
0 |
2 |
11 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Blin Emmanuel |
SVP, Chief Strategy Officer |
|
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
474 |
14,071 |
|
- |
|
Caforio Giovanni |
Chief Executive Officer |
|
2017-03-10 |
4 |
D |
$58.32 |
$2,611,686 |
D/D |
(44,782) |
172,418 |
|
- |
|
Caforio Giovanni |
Chief Executive Officer |
|
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,604 |
199,229 |
|
- |
|
Caforio Giovanni |
Chief Executive Officer |
|
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,541) |
155,499 |
|
- |
|
Caforio Giovanni |
Chief Executive Officer |
|
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,436 |
139,953 |
|
- |
|
Judge Ann Powell |
SVP, Global Human Resources |
|
2017-03-10 |
4 |
D |
$58.32 |
$810,181 |
D/D |
(13,892) |
42,571 |
|
- |
|
Judge Ann Powell |
SVP, Global Human Resources |
|
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,513 |
52,546 |
|
- |
|
Judge Ann Powell |
SVP, Global Human Resources |
|
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(663) |
31,351 |
|
- |
|
Judge Ann Powell |
SVP, Global Human Resources |
|
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,053 |
29,204 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2017-03-10 |
4 |
D |
$58.32 |
$442,882 |
D/D |
(7,594) |
63,733 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,484 |
68,911 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(312) |
59,069 |
|
- |
|
Caldarella Joseph C |
SVP & Controller |
|
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
917 |
57,994 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2017-02-28 |
4 |
OE |
$27.01 |
$610,372 |
D/D |
22,598 |
212,516 |
|
- |
|
Samuels Theodore R. Ii |
Director |
|
2017-02-27 |
4 |
B |
$56.77 |
$681,240 |
D/D |
12,000 |
12,000 |
2.39 |
- |
|
Emmens Matthew |
Director |
|
2017-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
260 |
|
- |
|
Bertolini Robert J |
Director |
|
2017-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
397 |
|
- |
|
Andreotti Lamberto |
Director |
|
2017-01-30 |
4 |
OE |
$27.01 |
$2,701,000 |
D/D |
100,000 |
957,931 |
|
- |
|
Elicker John E |
SVP, Public Affairs & IR |
|
2017-01-03 |
4 |
D |
$58.44 |
$19,870 |
D/D |
(340) |
55,892 |
|
- |
|
Elicker John E |
SVP, Public Affairs & IR |
|
2017-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
950 |
56,232 |
|
- |
|
Andreotti Lamberto |
Director |
|
2016-12-31 |
4 |
A |
$58.44 |
$24,954 |
D/D |
427 |
857,931 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2016-12-02 |
4 |
D |
$55.96 |
$161,333 |
D/D |
(2,883) |
189,918 |
|
- |
|
Bancroft Charles A |
EVP & Chief Financial Officer |
|
2016-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,403 |
192,801 |
|
- |
|
Elicker John E |
SVP, Public Affairs & IR |
|
2016-11-01 |
4 |
D |
$50.80 |
$11,328 |
D/D |
(223) |
55,282 |
|
- |
|
Elicker John E |
SVP, Public Affairs & IR |
|
2016-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
494 |
55,505 |
|
- |
|
953 Records found
|
|
Page 24 of 39 |
|
|